Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:795-801
Published online before print March 13, 2003, doi: 10.1161/01.ATV.0000066132.32063.F2
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
23/5/795    most recent
01.ATV.0000066132.32063.F2v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhan, Y.
Right arrow Articles by Iwao, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhan, Y.
Right arrow Articles by Iwao, H.
Related Collections
Right arrow Other Ethics and Policy
Right arrow Coagulation inhibitors
Right arrow Coumarins
Right arrow Glucose intolerance
Right arrow CV surgery: other
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:795.)
© 2003 American Heart Association, Inc.


Vascular Biology

Role of JNK, p38, and ERK in Platelet-Derived Growth Factor–Induced Vascular Proliferation, Migration, and Gene Expression

Yumei Zhan; Shokei Kim; Yasukatsu Izumi; Yasuhiro Izumiya; Takafumi Nakao; Hitoshi Miyazaki; Hiroshi Iwao

From the Department of Pharmacology, Osaka City University Medical School, Osaka, Japan, and Gene Experiment Center and Center for Tsukuba Advanced Research Alliance (H.M.), University of Tsukuba, Ibaraki, Japan.

Correspondence to Shokei Kim, MD, Department of Pharmacology, Osaka City University Medical School, Asahimachi, Abeno, Osaka 545-8585, Japan. E-mail kims{at}med.osaka-cu.ac.jp

Objective— We investigated the comparative roles of mitogen-activated protein (MAP) kinases, including c-Jun NH2-terminal kinase (JNK), extracellular signal-regulated kinase (ERK), and p38, in vascular smooth muscle cell (VSMC) proliferation, migration, and gene expression.

Methods and Results— VSMCs were infected with recombinant adenovirus containing dominant-negative mutants of ERK, p38, and JNK (Ad-DN-ERK, Ad-DN-p38, and Ad-DN-JNK, respectively) to specifically inhibit the respective MAP kinases and then stimulated with platelet-derived growth factor (PDGF)-BB. Ad-DN-ERK attenuated PDGF-BB–induced VSMC proliferation more potently than Ad-DN-p38 or Ad-DN-JNK, indicating the dominant role of ERK in VSMC proliferation. Ad-DN-ERK, Ad-DN-p38, and Ad-DN-JNK similarly inhibited PDGF-induced VSMC migration. Ad-DN-ERK and Ad-DN-JNK suppressed PDGF-BB–induced downregulation of cyclin-dependent kinase inhibitor p27Kip1, whereas Ad-DN-p38 decreased PDGF-BB–induced upregulation of p21Cip1. Ad-DN-ERK inhibited PDGF-BB–induced plasminogen activator inhibitor type-1 (PAI-1), monocyte chemoattractant protein-1, and transforming growth factor-ß1 expressions, Ad-DN-p38 blocked monocyte chemoattractant protein-1 and transforming growth factor-ß1 expression but not PAI-1, whereas Ad-DN-JNK suppressed only PAI-1 expression. Moreover, in vivo gene transfer of Ad-DN-p38 to rat carotid artery caused the inhibition of intimal hyperplasia by balloon injury, indicating the involvement of p38 in vascular remodeling in vivo.

Conclusions— We propose that these 3 MAP kinases participate in vascular diseases via differential molecular mechanisms and are new therapeutic targets for treatment of vascular diseases.


Key Words: platelet-derived growth factor • gene transfer • vascular smooth muscle cell • proliferation • gene expression




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
X. Guo, L. Nie, L. Esmailzadeh, J. Zhang, J. R. Bender, and M. M. Sadeghi
Endothelial and Smooth Muscle-derived Neuropilin-like Protein Regulates Platelet-derived Growth Factor Signaling in Human Vascular Smooth Muscle Cells by Modulating Receptor Ubiquitination
J. Biol. Chem., October 23, 2009; 284(43): 29376 - 29382.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
K. Ishizawa, N. Dorjsuren, Y. Izawa-Ishizawa, R. Sugimoto, Y. Ikeda, Y. Kihira, K. Kawazoe, S. Tomita, K. Tsuchiya, K. Minakuchi, et al.
Inhibitory effects of adiponectin on platelet-derived growth factor-induced mesangial cell migration
J. Endocrinol., August 1, 2009; 202(2): 309 - 316.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
Y.-M. Sue, C.-F. Cheng, C.-C. Chang, Y. Chou, C.-H. Chen, and S.-H. Juan
Antioxidation and anti-inflammation by haem oxygenase-1 contribute to protection by tetramethylpyrazine against gentamicin-induced apoptosis in murine renal tubular cells
Nephrol. Dial. Transplant., March 1, 2009; 24(3): 769 - 777.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. M. Lee, B. H. Jeon, K.-J. Won, C.-K. Lee, T.-K. Park, W. S. Choi, Y. M. Bae, H. S. Kim, S. K. Lee, S. H. Park, et al.
Gene Transfer of Redox Factor-1 Inhibits Neointimal Formation: Involvement of Platelet-Derived Growth Factor-{beta} Receptor Signaling via the Inhibition of the Reactive Oxygen Species-Mediated Syk Pathway
Circ. Res., January 30, 2009; 104(2): 219 - 227.
[Abstract] [Full Text] [PDF]


Home page
Cancer Prevention ResearchHome page
S. Lamy, V. Bedard, D. Labbe, H. Sartelet, C. Barthomeuf, D. Gingras, and R. Beliveau
The Dietary Flavones Apigenin and Luteolin Impair Smooth Muscle Cell Migration and VEGF Expression through Inhibition of PDGFR-{beta} Phosphorylation
Cancer Prevention Research, November 1, 2008; 1(6): 452 - 459.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
E. A. Lasater, W. K. Bessler, L. E. Mead, W. E. Horn, D. W. Clapp, S. J. Conway, D. A. Ingram, and F. Li
Nf1+/- mice have increased neointima formation via hyperactivation of a Gleevec sensitive molecular pathway
Hum. Mol. Genet., August 1, 2008; 17(15): 2336 - 2344.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
C. Bose and K. B. Udupa
Erythropoietin enhancement of rat pancreatic tumor cell proliferation requires the activation of ERK and JNK signals
Am J Physiol Cell Physiol, August 1, 2008; 295(2): C394 - C405.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Lamy, E. Beaulieu, D. Labbe, V. Bedard, A. Moghrabi, S. Barrette, D. Gingras, and R. Beliveau
Delphinidin, a dietary anthocyanidin, inhibits platelet-derived growth factor ligand/receptor (PDGF/PDGFR) signaling
Carcinogenesis, May 1, 2008; 29(5): 1033 - 1041.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Taketa, T. Matsumura, M. Yano, N. Ishii, T. Senokuchi, H. Motoshima, Y. Murata, S. Kim-Mitsuyama, T. Kawada, H. Itabe, et al.
Oxidized Low Density Lipoprotein Activates Peroxisome Proliferator-activated Receptor-{alpha} (PPAR{alpha}) and PPAR{gamma} through MAPK-dependent COX-2 Expression in Macrophages
J. Biol. Chem., April 11, 2008; 283(15): 9852 - 9862.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
N. G. Abraham and A. Kappas
Pharmacological and Clinical Aspects of Heme Oxygenase
Pharmacol. Rev., March 1, 2008; 60(1): 79 - 127.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. B. Morris, A. R. Olzinski, R. E. Bernard, K. Aravindhan, R. C. Mirabile, R. Boyce, R. N. Willette, and B. M. Jucker
p38 MAPK Inhibition Reduces Aortic Ultrasmall Superparamagnetic Iron Oxide Uptake in a Mouse Model of Atherosclerosis: MRI Assessment
Arterioscler Thromb Vasc Biol, February 1, 2008; 28(2): 265 - 271.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. Ni, Y. Zhan, H. He, E. Maynard, J. A. Balschi, and P. Oettgen
Ets-1 Is a Critical Transcriptional Regulator of Reactive Oxygen Species and p47phox Gene Expression in Response to Angiotensin II
Circ. Res., November 9, 2007; 101(10): 985 - 994.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
F. S. Santiago, H. Ishii, S. Shafi, R. Khurana, P. Kanellakis, R. Bhindi, M. J. Ramirez, A. Bobik, J. F. Martin, C. N. Chesterman, et al.
Yin Yang-1 Inhibits Vascular Smooth Muscle Cell Growth and Intimal Thickening by Repressing p21WAF1/Cip1 Transcription and p21WAF1/Cip1-Cdk4-Cyclin D1 Assembly
Circ. Res., July 20, 2007; 101(2): 146 - 155.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Khan, A. Agrotis, and A. Bobik
Understanding the role of transforming growth factor-{beta}1 in intimal thickening after vascular injury
Cardiovasc Res, May 1, 2007; 74(2): 223 - 234.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C.-K. Lee, H. M. Lee, H. J. Kim, H.-J. Park, K.-J. Won, H. Y. Roh, W. S. Choi, B. H. Jeon, T.-K. Park, and B. Kim
Syk contributes to PDGF-BB-mediated migration of rat aortic smooth muscle cells via MAPK pathways
Cardiovasc Res, April 1, 2007; 74(1): 159 - 168.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. T. Gerthoffer
Mechanisms of Vascular Smooth Muscle Cell Migration
Circ. Res., March 16, 2007; 100(5): 607 - 621.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Wada, M. Naito, H. Kenmochi, H. Tsuneki, and T. Sasaoka
Chronic Nicotine Exposure Enhances Insulin-Induced Mitogenic Signaling via Up-Regulation of {alpha}7 Nicotinic Receptors in Isolated Rat Aortic Smooth Muscle Cells
Endocrinology, February 1, 2007; 148(2): 790 - 799.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
P. K. Mehta and K. K. Griendling
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Am J Physiol Cell Physiol, January 1, 2007; 292(1): C82 - C97.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Chen, R. C. Budd, R. J. Kelm Jr, B. E. Sobel, and D. J. Schneider
Augmentation of Proliferation of Vascular Smooth Muscle Cells by Plasminogen Activator Inhibitor Type 1
Arterioscler Thromb Vasc Biol, August 1, 2006; 26(8): 1777 - 1783.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Yu, K. Sliedregt-Bol, H. Overkleeft, G. A. van der Marel, T. J.C. van Berkel, and E. A.L. Biessen
Therapeutic Potential of a Synthetic Peptide Inhibitor of Nuclear Factor of Activated T Cells as Antirestenotic Agent
Arterioscler Thromb Vasc Biol, July 1, 2006; 26(7): 1531 - 1537.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
F. Li, A. M. Munchhof, H. A. White, L. E. Mead, T. R. Krier, A. Fenoglio, S. Chen, X. Wu, S. Cai, F.-C. Yang, et al.
Neurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cells
Hum. Mol. Genet., June 1, 2006; 15(11): 1921 - 1930.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
A. M. Munchhof, F. Li, H. A. White, L. E. Mead, T. R. Krier, A. Fenoglio, X. Li, J. Yuan, F.-C. Yang, and D. A. Ingram
Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells
Hum. Mol. Genet., June 1, 2006; 15(11): 1858 - 1869.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Z. Chen, F. Y. Lee, K. N. Bhalla, and J. Wu
Potent Inhibition of Platelet-Derived Growth Factor-Induced Responses in Vascular Smooth Muscle Cells by BMS-354825 (Dasatinib)
Mol. Pharmacol., May 1, 2006; 69(5): 1527 - 1533.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
E. S. Jeon, H. Y. Song, M. R. Kim, H. J. Moon, Y. C. Bae, J. S. Jung, and J. H. Kim
Sphingosylphosphorylcholine induces proliferation of human adipose tissue-derived mesenchymal stem cells via activation of JNK
J. Lipid Res., March 1, 2006; 47(3): 653 - 664.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
U. Seay, D. Sedding, S. Krick, M. Hecker, W. Seeger, and O. Eickelberg
Transforming Growth Factor-{beta}-Dependent Growth Inhibition in Primary Vascular Smooth Muscle Cells Is p38-Dependent
J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1005 - 1012.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
B. Lee and S.-K. Moon
Resveratrol Inhibits TNF-{alpha}-Induced Proliferation and Matrix Metalloproteinase Expression in Human Vascular Smooth Muscle Cells
J. Nutr., December 1, 2005; 135(12): 2767 - 2773.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Shinohara, S. Kawashima, T. Yamashita, T. Takaya, R. Toh, T. Ishida, T. Ueyama, N. Inoue, K.-i. Hirata, and M. Yokoyama
Xenogenic smooth muscle cell immunization reduces neointimal formation in balloon-injured rabbit carotid arteries
Cardiovasc Res, November 1, 2005; 68(2): 249 - 258.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
K. K. Lu, S. E. Armstrong, R. Ginnan, and H. A. Singer
Adhesion-dependent activation of CaMKII and regulation of ERK activation in vascular smooth muscle
Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1343 - C1350.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Shen, S. P. Halenda, M. Sturek, and P. A. Wilden
Cell-Signaling Evidence for Adenosine Stimulation of Coronary Smooth Muscle Proliferation via the A1 Adenosine Receptor
Circ. Res., September 16, 2005; 97(6): 574 - 582.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Ohtsu, M. Mifune, G. D. Frank, S. Saito, T. Inagami, S. Kim-Mitsuyama, Y. Takuwa, T. Sasaki, J. D. Rothstein, H. Suzuki, et al.
Signal-Crosstalk Between Rho/ROCK and c-Jun NH2-Terminal Kinase Mediates Migration of Vascular Smooth Muscle Cells Stimulated by Angiotensin II
Arterioscler Thromb Vasc Biol, September 1, 2005; 25(9): 1831 - 1836.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Md. R. Abid, K. Yano, S. Guo, V. I. Patel, G. Shrikhande, K. C. Spokes, C. Ferran, and W. C. Aird
Forkhead Transcription Factors Inhibit Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia
J. Biol. Chem., August 19, 2005; 280(33): 29864 - 29873.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Ollinger, M. Bilban, A. Erat, A. Froio, J. McDaid, S. Tyagi, E. Csizmadia, A. V. Graca-Souza, A. Liloia, M. P. Soares, et al.
Bilirubin: A Natural Inhibitor of Vascular Smooth Muscle Cell Proliferation
Circulation, August 16, 2005; 112(7): 1030 - 1039.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Sakakibara, K. Kubota, B. Worku, E. J. Ryer, J. P. Miller, A. Koff, K. C. Kent, and B. Liu
PDGF-BB Regulates p27 Expression through ERK-dependent RNA Turn-over in Vascular Smooth Muscle Cells
J. Biol. Chem., July 8, 2005; 280(27): 25470 - 25477.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. T. Grygielko, W. M. Martin, C. Tweed, P. Thornton, J. Harling, D. P. Brooks, and N. J. Laping
Inhibition of Gene Markers of Fibrosis with a Novel Inhibitor of Transforming Growth Factor-{beta} Type I Receptor Kinase in Puromycin-Induced Nephritis
J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 943 - 951.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Katsuma, N. Hatae, T. Yano, Y. Ruike, M. Kimura, A. Hirasawa, and G. Tsujimoto
Free Fatty Acids Inhibit Serum Deprivation-induced Apoptosis through GPR120 in a Murine Enteroendocrine Cell Line STC-1
J. Biol. Chem., May 20, 2005; 280(20): 19507 - 19515.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Djordjevic, R. S. BelAiba, S. Bonello, J. Pfeilschifter, J. Hess, and A. Gorlach
Human Urotensin II Is a Novel Activator of NADPH Oxidase in Human Pulmonary Artery Smooth Muscle Cells
Arterioscler Thromb Vasc Biol, March 1, 2005; 25(3): 519 - 525.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Senokuchi, T. Matsumura, M. Sakai, M. Yano, T. Taguchi, T. Matsuo, K. Sonoda, D. Kukidome, K. Imoto, T. Nishikawa, et al.
Statins Suppress Oxidized Low Density Lipoprotein-induced Macrophage Proliferation by Inactivation of the Small G Protein-p38 MAPK Pathway
J. Biol. Chem., February 25, 2005; 280(8): 6627 - 6633.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Sakamoto, T. Murata, H. Chuma, M. Hori, and H. Ozaki
Fluvastatin Prevents Vascular Hyperplasia by Inhibiting Phenotype Modulation and Proliferation Through Extracellular Signal-Regulated Kinase 1 and 2 and p38 Mitogen-Activated Protein Kinase Inactivation in Organ-Cultured Artery
Arterioscler Thromb Vasc Biol, February 1, 2005; 25(2): 327 - 333.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
R. Ricci, G. Sumara, I. Sumara, I. Rozenberg, M. Kurrer, A. Akhmedov, M. Hersberger, U. Eriksson, F. R. Eberli, B. Becher, et al.
Requirement of JNK2 for Scavenger Receptor A-Mediated Foam Cell Formation in Atherogenesis
Science, November 26, 2004; 306(5701): 1558 - 1561.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Yamaguchi, M. Igarashi, A. Hirata, N. Sugae, H. Tsuchiya, Y. Jimbu, M. Tominaga, and T. Kato
Altered PDGF-BB-Induced p38 MAP Kinase Activation in Diabetic Vascular Smooth Muscle Cells: Roles of Protein Kinase C-{delta}
Arterioscler Thromb Vasc Biol, November 1, 2004; 24(11): 2095 - 2101.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. Mifune, H. Ohtsu, H. Suzuki, G. D. Frank, T. Inagami, H. Utsunomiya, P. J. Dempsey, and S. Eguchi
Signal transduction of betacellulin in growth and migration of vascular smooth muscle cells
Am J Physiol Cell Physiol, September 1, 2004; 287(3): C807 - C813.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-K. Moon, H.-M. Kim, Y.-C. Lee, and C.-H. Kim
Disialoganglioside (GD3) Synthase Gene Expression Suppresses Vascular Smooth Muscle Cell Responses via the Inhibition of ERK1/2 Phosphorylation, Cell Cycle Progression, and Matrix Metalloproteinase-9 Expression
J. Biol. Chem., August 6, 2004; 279(32): 33063 - 33070.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
V. Andres
Control of vascular cell proliferation and migration by cyclin-dependent kinase signalling: new perspectives and therapeutic potential
Cardiovasc Res, July 1, 2004; 63(1): 11 - 21.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Prasad, A. Z. Fernandis, Y. Rao, and R. K. Ganju
Slit Protein-mediated Inhibition of CXCR4-induced Chemotactic and Chemoinvasive Signaling Pathways in Breast Cancer Cells
J. Biol. Chem., March 5, 2004; 279(10): 9115 - 9124.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Izumi, S. Kim, M. Yoshiyama, Y. Izumiya, K. Yoshida, A. Matsuzawa, H. Koyama, Y. Nishizawa, H. Ichijo, J. Yoshikawa, et al.
Activation of Apoptosis Signal-Regulating Kinase 1 in Injured Artery and Its Critical Role in Neointimal Hyperplasia
Circulation, December 2, 2003; 108(22): 2812 - 2818.
[Abstract] [Full Text] [PDF]